Il- kanċer tal- pulmun huwa tip ta ' kanċer li jibda fil- pulmun.
Dan iseħħ meta ċelloli anormali fil- pulmun jikbru u jimmultiplikaw bla kontroll, u jiffurmaw tumur.
Hemm żewġ tipi ewlenin ta' kanċer tal-pulmun: kanċer tal-pulmun b'ċelloli mhux żgħar (NSCLC) u kanċer tal-pulmun b'ċelloli żgħar (SCLC). Il-kawża l-aktar komuni ta' kanċer tal-pulmun hija t-tipjip, iżda jista' jkun ikkawżat ukoll minn esponiment għat-tipjip sekondarju, t-tniġġis tal-arja, u fatturi ambjentali oħra.
Is- sintomi tal- kanċer tal- pulmun jistgħu jinkludu sogħla persistenti, uġigħ fis- sider, nuqqas taʼ nifs, u sogħla taʼ demm.
L- għażliet taʼ trattament għall- kanċer tal- pulmun jinkludu kirurġija, radioterapija, kimoterapija, terapija mmirata, u immunoterapija.
Detezzjoni u trattament bikrija jistgħu jtejbu l- ċansijiet taʼ sopravivenza.
Liu Z, Zhao W, Yang R: MiR-1246 is responsible for lung cancer cells-derived exosomes-mediated promoting effects on lung cancer stemness via targeting TRIM17. Environ Toxicol. 2022, 37 (11): 2651-2659.
Lung Cancer Screening. Semin Respir Crit Care Med. 2022, 43 (6): 839-850.
Guan Y, Ren M, Guo D, He Y: [Research Progress on Lung Cancer Screening]. Zhongguo Fei Ai Za Zhi. 2020, 23 (11): 954-960.
Yu F, Xiao R, Li X, Hu Z, Cai L, He F: Combined effects of lung disease history, environmental exposures, and family history of lung cancer to susceptibility of lung cancer in Chinese non-smokers. Respir Res. 2021, 22 (1): 210.
Liu LZ, Qian GS, Zhou XD: [Expression of a new lung cancer drug resistance-related gene in lung cancer tissues and lung cancer cell strains]. Ai Zheng. 2003, 22 (2): 171-4.
Fan L, Wang Y, Zhou Y, Li Q, Yang W, Wang S, Shan F, Zhang X, Shi J, Chen W, Liu SY: Lung Cancer Screening with Low-Dose CT: Baseline Screening Results in Shanghai. Acad Radiol. 2019, 26 (10): 1283-1291.
Kathuria H, Gesthalter Y, Spira A, Brody JS, Steiling K: Updates and controversies in the rapidly evolving field of lung cancer screening, early detection, and chemoprevention. Cancers (Basel). 2014, 6 (2): 1157-79.
Jin Y, Zhou X, He X: [The general measurement of genetic factors on lung cancer in Xuanwei, China]. Zhongguo Fei Ai Za Zhi. 2001, 4 (5): 354-6.
Tneħħija ta ' responsabbiltà: mediku
Dan is-sit tal-web huwa pprovdut għal skopijiet edukattivi u ta' informazzjoni biss u ma jikkostitwixxix l-għoti ta' parir mediku jew servizzi professjonali.
L- informazzjoni pprovduta m'għandhiex tintuża għad- dijanjosi jew it- trattament taʼ problema jew marda tas- saħħa, u dawk li jfittxu parir mediku personali għandhom jikkonsultaw maʼ tabib liċenzjat.
Jekk jogħġbok innota li n-netwerk newrali li jiġġenera t-tweġibiet għall-mistoqsijiet, huwa speċjalment mhux preċiż meta niġu għal kontenut numeriku. Pereżempju, in-numru ta' nies dijanjostikati b'marda speċifika.
Dejjem fittex il-parir tat-tabib tiegħek jew ta' fornitur tas-saħħa kwalifikat ieħor dwar kundizzjoni medika. Qatt ma tinjora l-parir mediku professjonali jew id-dewmien fit-tfittxija tiegħu minħabba xi ħaġa li qrajt f'dan il-websajt. Jekk taħseb li tista' jkollok emerġenza medika, ċempel 911 jew mur l-eqreb kamra tal-emerġenza immedjatament. L-ebda relazzjoni bejn tabib u pazjent ma tinħoloq minn dan il-websajt jew l-użu tagħha. La BioMedLib u lanqas l-impjegati tagħha, u lanqas kwalunkwe kontributur għal dan il-websajt, ma jagħmel xi rappreżentazzjonijiet, espressi jew impliċiti, fir-rigward tal-informazzjoni pprovduta hawnhekk jew għall-użu tagħha.
Riżerva ta' responsabbiltà: drittijiet tal-awtur
L-Att dwar id-Drittijiet tal-Awtur tal-Millennju Diġitali tal-1998, 17 U.S.C. § 512 (il-"DMCA") jipprovdi rikors għas-sidien tad-drittijiet tal-awtur li jemmnu li materjal li jidher fuq l-Internet jikser id-drittijiet tagħhom skont il-liġi tad-drittijiet tal-awtur tal-Istati Uniti.
Jekk temmen b'bona fidi li kwalunkwe kontenut jew materjal magħmul disponibbli b'rabta mal-websajt jew is-servizzi tagħna jikser id-drittijiet tal-awtur tiegħek, inti (jew l-aġent tiegħek) tista' tibgħatilna avviż li jitlob li l-kontenut jew il-materjal jitneħħa, jew li l-aċċess għalih jiġi mblukkat.
Id-DMCA teħtieġ li n-notifika tiegħek ta' ksur allegat tad-drittijiet tal-awtur tinkludi l-informazzjoni li ġejja: (1) deskrizzjoni tax-xogħol protett bid-drittijiet tal-awtur li huwa s-suġġett ta' ksur allegat; (2) deskrizzjoni tal-kontenut allegatament li jikser id-drittijiet tal-awtur u informazzjoni suffiċjenti biex inkunu nistgħu nsibu l-kontenut; (3) informazzjoni ta' kuntatt għalik, inkluż l-indirizz tiegħek, in-numru tat-telefon u l-indirizz tal-email; (4) dikjarazzjoni minnek li għandek twemmin ta' fidi tajba li l-kontenut bil-mod li dwaru l-ilment ġie ppreżentat mhuwiex awtorizzat mid-detentur tad-drittijiet tal-awtur, jew mill-aġent tiegħu, jew mill-operazzjoni ta' kwalunkwe liġi;
(5) stqarrija minnek, iffirmata taħt il-piena ta' perjuri, li l-informazzjoni fin-notifika hija preċiża u li għandek l-awtorità li tinforza d-drittijiet tal-awtur li huma ddikjarati li ġew miksura;
u (6) firma fiżika jew elettronika tas-sid tad-drittijiet tal-awtur jew ta' persuna awtorizzata li taġixxi f'isem is-sid tad-drittijiet tal-awtur.
In-nuqqas li tinkludi l-informazzjoni kollha ta' hawn fuq jista' jwassal għal dewmien fit-trattament tal-ilment tiegħek.
Kuntatt
Jekk jogħġbok ibgħatilna email b'kull mistoqsija / suġġeriment.
What is lung cancer?
Lung cancer is a type of cancer that begins in the lungs.
It occurs when abnormal cells in the lungs grow and multiply uncontrollably, forming a tumor.
There are two main types of lung cancer: non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC). The most common cause of lung cancer is smoking, but it can also be caused by exposure to secondhand smoke, air pollution, and other environmental factors.
Symptoms of lung cancer may include a persistent cough, chest pain, shortness of breath, and coughing up blood.
Treatment options for lung cancer include surgery, radiation therapy, chemotherapy, targeted therapy, and immunotherapy.
Early detection and treatment can improve the chances of survival.
Disclaimer: medical
This web site is provided for educational and informational purposes only and does not constitute providing medical advice or professional services.
The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician.
Please note the neural net that generates answers to the questions, is specially inaccurate when it comes to numeric content. For example, the number of people diagnosed with a specific disease.
Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. Neither BioMedLib nor its employees, nor any contributor to this web site, makes any representations, express or implied, with respect to the information provided herein or to its use.
Disclaimer: copyright
The Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the “DMCA”) provides recourse for copyright owners who believe that material appearing on the Internet infringes their rights under U.S. copyright law. If you believe in good faith that any content or material made available in connection with our website or services infringes your copyright, you (or your agent) may send us a notice requesting that the content or material be removed, or access to it blocked. Notices must be sent in writing by email (see 'Contact' section for email address) . The DMCA requires that your notice of alleged copyright infringement include the following information: (1) description of the copyrighted work that is the subject of claimed infringement; (2) description of the alleged infringing content and information sufficient to permit us to locate the content; (3) contact information for you, including your address, telephone number and email address; (4) a statement by you that you have a good faith belief that the content in the manner complained of is not authorized by the copyright owner, or its agent, or by the operation of any law; (5) a statement by you, signed under penalty of perjury, that the information in the notification is accurate and that you have the authority to enforce the copyrights that are claimed to be infringed; and (6) a physical or electronic signature of the copyright owner or a person authorized to act on the copyright owner’s behalf. Failure to include all of the above information may result in the delay of the processing of your complaint.
Madwar
BioMedLib juża kompjuters awtomatizzati (algoritmi ta' tagħlim tal-magni) biex jiġġenera koppji ta' mistoqsijiet u tweġibiet.
Aħna nibdew b'35 miljun pubblikazzjoni bijomedika ta' PubMed/Medline. Ukoll, paġni tal-web ta' RefinedWeb.
